Skip to main content
Erschienen in: Supportive Care in Cancer 11/2019

30.08.2019 | Letter to the Editor

In response to the director letter “Polyphenols, Mediterranean diet, and colon cancer”

verfasst von: Miren Orive, Nerea González, Jose Maria Quintana

Erschienen in: Supportive Care in Cancer | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Excerpt

We appreciate the contribution made to our manuscript [1] by Mattioli AV et al. in their letter to the director [2]. We agree with them that lifestyle and nutrition strongly influence the development and outcome of colon cancer [3]. As they also showed, it is well documented that hospitalized malnourished patients present a higher risk of complications, morbidity, mortality, readmissions, significantly longer hospital stays, and higher quality of life decreased than those nourished [46]. Malnourishment is particularly frequent in colorectal patients due to the characteristics of the organs affected by the disease, its severity, and the usually older age of patients [3]. To measure nutritional status, there are different objective indicators. In Spain, a CONUT (Malnutrition Control) screening system [7] has been validated to detect, with, theoretically, routine analyses (albumin, lymphocytes, cholesterol), those patients with possible malnutrition at hospital admission. In our study, we collected these analytic parameters, but some of them, as lymphocyte number or albumin level, had a high rate of missing data which would had compromised the validity of our models if included on them. Therefore, we decided not to consider them for our models. …
Literatur
4.
Zurück zum Zitat Lobo Támer G, Ruiz López MD, Pérez de la Cruz AJ (2009) Hospital malnutrition: relation between the hospital length of stay and the rate of early readmissions. Med Clin (Barc) 132(10):377–384CrossRef Lobo Támer G, Ruiz López MD, Pérez de la Cruz AJ (2009) Hospital malnutrition: relation between the hospital length of stay and the rate of early readmissions. Med Clin (Barc) 132(10):377–384CrossRef
5.
Zurück zum Zitat Hiura G, Lebwohl B, Seres DS (2019) Malnutrition diagnosis in critically ill patients using 2012 academy of nutrition and dietetics/American Society for Parenteral and Enteral Nutrition standardized diagnostic characteristics is associated with longer hospital and intensive care unit length of stay and increased in-hospital mortality. JPEN J Parenter Enteral Nutr Hiura G, Lebwohl B, Seres DS (2019) Malnutrition diagnosis in critically ill patients using 2012 academy of nutrition and dietetics/American Society for Parenteral and Enteral Nutrition standardized diagnostic characteristics is associated with longer hospital and intensive care unit length of stay and increased in-hospital mortality. JPEN J Parenter Enteral Nutr
6.
Zurück zum Zitat Siegel S, Fan L, Goldman A, Higgins J, Goates S, Partridge J (2019) Impact of a nutrition-focused quality improvement intervention on hospital length of stay. J Nurs Care Qual 34(3):203–209CrossRefPubMed Siegel S, Fan L, Goldman A, Higgins J, Goates S, Partridge J (2019) Impact of a nutrition-focused quality improvement intervention on hospital length of stay. J Nurs Care Qual 34(3):203–209CrossRefPubMed
7.
Zurück zum Zitat González-Madroño A, Mancha A, Rodríguez FJ, Culebras J, de Ulibarri JI (2012) Confirming the validity of the CONUT system for early detection and monitoring of clinical undernutrition: comparison with two logistic regression models developed using SGA as the gold standard. Nutr Hosp 27(2):564–571PubMed González-Madroño A, Mancha A, Rodríguez FJ, Culebras J, de Ulibarri JI (2012) Confirming the validity of the CONUT system for early detection and monitoring of clinical undernutrition: comparison with two logistic regression models developed using SGA as the gold standard. Nutr Hosp 27(2):564–571PubMed
Metadaten
Titel
In response to the director letter “Polyphenols, Mediterranean diet, and colon cancer”
verfasst von
Miren Orive
Nerea González
Jose Maria Quintana
Publikationsdatum
30.08.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 11/2019
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05011-9

Weitere Artikel der Ausgabe 11/2019

Supportive Care in Cancer 11/2019 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.